OncoGenex Announces Target Number of Events Reached in Phase 3 SYNERGY Trial of Custirsen in Metastatic Castrate-Resistant Prostate Cancer
BOTHELL, Wash. and VANCOUVER, British Columbia, Feb.
Tulane University School of Medicine participates in pilot program
Lilly Diabetes Donates 91 Scholarships to Support the American Diabetes Association's Diabetes Summer Camp Program
More than half a million dollars donated to help children with diabetes attend camp since 2008
Aegerion Pharmaceuticals' JUXTAPID (lomitapide) Capsules Approved in Canada for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma
THOUSAND OAKS, Calif., Feb.